Notice Pursuant to the National Cooperative Research and Production Act of 1993-Cooperative Research Group on ROS-Industrial Consortium-Americas, 16420 [2017-06586]
Download as PDF
16420
Federal Register / Vol. 82, No. 63 / Tuesday, April 4, 2017 / Notices
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Cooperative Research
Group on ROS-Industrial ConsortiumAmericas
Notice is hereby given that, on
February 21, 2017, pursuant to Section
6(a) of the National Cooperative
Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (‘‘the Act’’),
Southwest Research Institute—
Cooperative Research Group on ROSIndustrial Consortium-Americas (‘‘RICAmericas’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
Membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Air Force Mantech (AFRL/
RXM), Wright-Patterson Air Force Base,
OH; and 3M, St. Paul, MN, have been
added as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open and RIC-Americas
intends to file additional written
notifications disclosing all changes in
membership or planned activities.
On April 30, 2014, RIC-Americas filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on June 9, 2014 (79 FR
32999).
The last notification was filed with
the Department on November 30, 2016.
A notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on January 11, 2017 (82 FR 3360).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Network Centric
Operations Industry Consortium, Inc.
(‘‘NCOIC’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Compusult Systems, Inc.,
Reston, VA; and Scott Goessling
(individual member), Mansfield, TX,
have been added as parties to this
venture.
Also, International Business Machines
Corp., Armonk, NY, has withdrawn as a
party to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and NCOIC
intends to file additional written
notifications disclosing all changes in
membership.
On November 19, 2004, NCOIC filed
its original notification pursuant to
Section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to Section
6(b) of the Act on February 2, 2005 (70
FR 5486).
The last notification was filed with
the Department on May 26, 2016. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on June 21, 2016 (81 FR 40351).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust
Division.
[FR Doc. 2017–06585 Filed 4–3–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
[FR Doc. 2017–06586 Filed 4–3–17; 8:45 am]
Importer of Controlled Substances
Application: Xcelience
BILLING CODE P
ACTION:
asabaliauskas on DSK3SPTVN1PROD with NOTICES
DEPARTMENT OF JUSTICE
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Network Centric
Operations Industry Consortium, Inc.
Notice is hereby given that, on March
13, 2017, pursuant to Section 6(a) of the
National Cooperative Research and
16:21 Apr 03, 2017
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration in accordance
with 21 CFR 1301.34(a) on or before
May 4, 2017. Such persons may also file
a written request for a hearing on the
application pursuant to 21 CFR 1301.43
on or before May 4, 2017.
DATES:
Antitrust Division
VerDate Sep<11>2014
Notice of application.
Jkt 241001
PO 00000
Frm 00087
Fmt 4703
Sfmt 9990
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix of subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
September 30, 2016, Xcelience, 4901
West Grace Street, Tampa, Florida
33607 applied to be registered as an
importer of amphetamine (1100), a basic
class of controlled substance listed in
schedule II.
The company plans to import the
listed controlled substance in finished
dosage form for clinical trials, research
and analytical purposes.
The import of this class of controlled
substance will be granted only for
analytical testing, research and clinical
trials. This authorization does not
extend to the import of a finished FDA
approved or non-approved dosage form
for commercial sale.
SUPPLEMENTARY INFORMATION:
Dated: March 24, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017–06555 Filed 4–3–17; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\04APN1.SGM
04APN1
Agencies
[Federal Register Volume 82, Number 63 (Tuesday, April 4, 2017)]
[Notices]
[Page 16420]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06586]
[[Page 16420]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Cooperative Research Group on ROS-Industrial
Consortium-Americas
Notice is hereby given that, on February 21, 2017, pursuant to
Section 6(a) of the National Cooperative Research and Production Act of
1993, 15 U.S.C. 4301 et seq. (``the Act''), Southwest Research
Institute--Cooperative Research Group on ROS-Industrial Consortium-
Americas (``RIC-Americas'') has filed written notifications
simultaneously with the Attorney General and the Federal Trade
Commission disclosing changes in its Membership. The notifications were
filed for the purpose of extending the Act's provisions limiting the
recovery of antitrust plaintiffs to actual damages under specified
circumstances. Specifically, Air Force Mantech (AFRL/RXM), Wright-
Patterson Air Force Base, OH; and 3M, St. Paul, MN, have been added as
parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open and RIC-Americas intends to file
additional written notifications disclosing all changes in membership
or planned activities.
On April 30, 2014, RIC-Americas filed its original notification
pursuant to Section 6(a) of the Act. The Department of Justice
published a notice in the Federal Register pursuant to Section 6(b) of
the Act on June 9, 2014 (79 FR 32999).
The last notification was filed with the Department on November 30,
2016. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on January 11, 2017 (82 FR 3360).
Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2017-06586 Filed 4-3-17; 8:45 am]
BILLING CODE P